7-33905589-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBS1BS2
The NM_001365308.1(BMPER):c.-25C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00171 in 1,609,696 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0093 ( 20 hom., cov: 29)
Exomes 𝑓: 0.00092 ( 19 hom. )
Consequence
BMPER
NM_001365308.1 5_prime_UTR
NM_001365308.1 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.36
Genes affected
BMPER (HGNC:24154): (BMP binding endothelial regulator) This gene encodes a secreted protein that interacts with, and inhibits bone morphogenetic protein (BMP) function. It has been shown to inhibit BMP2- and BMP4-dependent osteoblast differentiation and BMP-dependent differentiation of the chondrogenic cells. Mutations in this gene are associated with a lethal skeletal disorder, diaphanospondylodysostosis. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 7-33905589-C-A is Benign according to our data. Variant chr7-33905589-C-A is described in ClinVar as [Benign]. Clinvar id is 360095.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00932 (1416/151910) while in subpopulation AFR AF= 0.0328 (1358/41376). AF 95% confidence interval is 0.0314. There are 20 homozygotes in gnomad4. There are 653 alleles in male gnomad4 subpopulation. Median coverage is 29. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 20 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BMPER | NM_001365308.1 | c.-25C>A | 5_prime_UTR_variant | 1/15 | ENST00000649409.2 | ||
BMPER | NM_001410872.1 | c.-25C>A | 5_prime_UTR_variant | 1/14 | |||
BMPER | NM_133468.5 | c.-25C>A | 5_prime_UTR_variant | 2/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BMPER | ENST00000649409.2 | c.-25C>A | 5_prime_UTR_variant | 1/15 | NM_001365308.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00931 AC: 1414AN: 151806Hom.: 20 Cov.: 29
GnomAD3 genomes
AF:
AC:
1414
AN:
151806
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00266 AC: 653AN: 245746Hom.: 8 AF XY: 0.00177 AC XY: 237AN XY: 133660
GnomAD3 exomes
AF:
AC:
653
AN:
245746
Hom.:
AF XY:
AC XY:
237
AN XY:
133660
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000915 AC: 1334AN: 1457786Hom.: 19 Cov.: 32 AF XY: 0.000752 AC XY: 545AN XY: 725210
GnomAD4 exome
AF:
AC:
1334
AN:
1457786
Hom.:
Cov.:
32
AF XY:
AC XY:
545
AN XY:
725210
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00932 AC: 1416AN: 151910Hom.: 20 Cov.: 29 AF XY: 0.00879 AC XY: 653AN XY: 74268
GnomAD4 genome
AF:
AC:
1416
AN:
151910
Hom.:
Cov.:
29
AF XY:
AC XY:
653
AN XY:
74268
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Diaphanospondylodysostosis Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at